Invention Grant
- Patent Title: Wnt protein signalling inhibitors
- Patent Title (中): Wnt蛋白信号传导抑制剂
-
Application No.: US12994661Application Date: 2009-05-27
-
Publication No.: US08445491B2Publication Date: 2013-05-21
- Inventor: Lawrence Lum , Michael G. Roth , Baozhi Chen , Chuo Chen , Michael E. Dodge , Wei Tang
- Applicant: Lawrence Lum , Michael G. Roth , Baozhi Chen , Chuo Chen , Michael E. Dodge , Wei Tang
- Applicant Address: US TX Austin
- Assignee: The Board of Regents of the University of Texas System
- Current Assignee: The Board of Regents of the University of Texas System
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- International Application: PCT/US2009/045340 WO 20090527
- International Announcement: WO2009/155001 WO 20091223
- Main IPC: C07D209/94
- IPC: C07D209/94 ; C07D239/54 ; C07D401/12 ; C07D401/14 ; C07D403/10
Abstract:
The present invention generally relates to protein signalling. In particular, compounds that inhibit the Wnt protein signalling pathway are disclosed. Such compounds may be used in the treatment of Wnt protein signalling-related diseases and conditions such as cancer, degenerative diseases, type II diabetes and osteopetrosis.
Public/Granted literature
- US20110136813A1 WNT PROTEIN SIGNALLING INHIBITORS Public/Granted day:2011-06-09
Information query
